|
| 35972811 | Safe delivery of systemic anti-cancer treatment for skin cancers during the COVID-19 pandemic. | J Eur Acad Dermatol Venereol | 2023 |
| 37802612 | <b>CO</b>mparing Urolift and <b>S</b>tandard <b>T</b>ransurethral resection of prostate <b>A</b>head of <b>R</b>adiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study. | BMJ Open | 2023 |
| 37291902 | British Society for Paediatric and Adolescent Dermatology assessment and support of mental health in children and young people with skin conditions: a multidisciplinary expert consensus statement and recommendations. | Br J Dermatol | 2023 |
| 37009414 | Clinical, genetic, epidemiologic, evolutionary, and functional delineation of <i>TSPEAR</i>-related autosomal recessive ectodermal dysplasia 14. | HGG Adv | 2023 |
| 37128990 | Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review. | Future Oncol | 2023 |
| 36787284 | Topical steroid withdrawal is not a myth. Comment on '#corticophobia: a review on online misinformation related to topical steroids'. | Clin Exp Dermatol | 2023 |
| 36689522 | Biallelic TUFT1 variants cause woolly hair, superficial skin fragility and desmosomal defects. | Br J Dermatol | 2023 |
| 36689518 | Birth incidence and outcome of harlequin ichthyosis and collodion membrane in the UK and Ireland: a national 2-year prospective surveillance study. | Br J Dermatol | 2023 |
| 36637151 | Potency of topical steroids should be clearly labelled on all packaging. | Br J Dermatol | 2023 |
| 34785188 | Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review. | Eur Urol Oncol | 2022 |
| 35382557 | Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic. | Future Oncol | 2022 |
| 35840733 | Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave. | Br J Cancer | 2022 |
| 35833942 | Topical steroid withdrawal syndrome: time to bridge the gap. | Br J Dermatol | 2022 |
| 35596596 | Achenbach syndrome: no need for skin biopsy. | Clin Exp Dermatol | 2022 |
| 35488333 | Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19. | BMC Urol | 2022 |
| 35783588 | Impact of the COVID-19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan. | BJUI Compass | 2022 |
| 35417006 | COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry. | J Natl Cancer Inst | 2022 |
| 36578462 | A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer. | Eur Urol Open Sci | 2022 |
| 36172860 | Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre. | Future Oncol | 2022 |
| 36291905 | A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology. | Cancers (Basel) | 2022 |
| 36291823 | Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review. | Cancers (Basel) | 2022 |
| 36375808 | Cancer care for Ukrainian refugees: Strategic impact assessments in the early days of the conflict. | J Cancer Policy | 2022 |
| 33845703 | Outcomes of head and neck cancer management from two cancer centres in Southern and Northern Europe during the first wave of COVID-19. | Tumori | 2022 |
| 34920915 | Qualitative Analysis of Interviews and Focus Groups Exploring Factors Contributing to Adherence to GnRH Agonists in Men with Prostate Cancer. | Semin Oncol Nurs | 2022 |
| 35034514 | The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer. | Future Oncol | 2022 |
| 34999892 | Mutations in the ribosome biogenesis factor gene LTV1 are linked to LIPHAK syndrome, a novel poikiloderma-like disorder. | Hum Mol Genet | 2022 |
| 35053432 | The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre. | Cancers (Basel) | 2022 |
| 34927719 | The epidemiology of epidermolysis bullosa in England and Wales: data from the national epidermolysis bullosa database. | Br J Dermatol | 2022 |
| 34817562 | Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry. | JAMA Oncol | 2022 |
| 33476581 | Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients. | Cancer Cell | 2021 |
| 33896710 | Update from the ReIMAGINE Prostate Cancer Screening Study NCT04063566: Inviting Men for Prostate Cancer Screening Using Magnetic Resonance Imaging. | Eur Urol Focus | 2021 |
| 33507907 | The need for supportive mental wellbeing interventions in bladder cancer patients: A systematic review of the literature. | PLoS One | 2021 |
| 33753569 | Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score. | J Immunother Cancer | 2021 |
| 33808375 | Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan. | Cancers (Basel) | 2021 |
| 33657677 | Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus. | Br J Dermatol | 2021 |
| 34497669 | Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective. | Ther Adv Med Oncol | 2021 |
| 34789334 | ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement. | Res Involv Engagem | 2021 |
| 34625412 | Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review. | BMJ Open | 2021 |
| 34771701 | Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis. | Cancers (Basel) | 2021 |
| 34593491 | ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI. | BMJ Open | 2021 |
| 34298785 | COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience. | Cancers (Basel) | 2021 |
| 34271831 | Designing a Pragmatic Intervention to Help Improve the Bladder Cancer Patient Experience. | Inquiry | 2021 |
| 34213357 | The importance of patient and public involvement in cancer research: time to create a new job profile. | Future Oncol | 2021 |
| 34069565 | COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients. | Cancers (Basel) | 2021 |
| 33932726 | Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study. | Eur J Cancer | 2021 |
| 34207042 | Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma. | Cancers (Basel) | 2021 |
| 33402736 | The effectiveness of the Guy's Rapid Diagnostic Clinic (RDC) in detecting cancer and serious conditions in vague symptom patients. | Br J Cancer | 2021 |
| 31120550 | Happle-Tinschert, Curry-Jones and segmental basal cell naevus syndromes, overlapping disorders caused by somatic mutations in hedgehog signalling genes: the mosaic hedgehog spectrum. | Br J Dermatol | 2020 |
| 31749140 | Podiatrists gaining a foothold. | Br J Dermatol | 2020 |
| 32017015 | Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. | Br J Dermatol | 2020 |